Effects of coenzyme Q10 in new indications with antioxidant vitamin deficiency

Journal of Nutritional and Environmental Medicine

Volumn 9, Issue 3, 1999, Pages 223-228

  Singh, R B ^a   Singh, M M ^b  

^a Medical Hospital   (India)

^b S N MEDICAL COLLEGE   (India)

Author keywords

Antioxidant; Glomerulonephritis; Motor neurone disease; Polymyositis; Renal failure; Ubiquinone; Vitamin

Indexed keywords

ANTIOXIDANT; CORTICOSTEROID; FREE RADICAL; UBIDECARENONE;

ACUTE GLOMERULONEPHRITIS; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; CASE REPORT; CLINICAL TRIAL; HUMAN; KIDNEY FAILURE; MALE; ORAL DRUG ADMINISTRATION; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; VITAMIN DEFICIENCY;

EID: 0032858120     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.1080/13590849961636     Document Type: Review

References (10)

1. Ernster L, Dollner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995; 1271: 195-204.
2. Singh RB, Niaz MA, Rastogi MA, Rastogi SS. Coenzyme Q in cardiovascular disease. J Physicians India 1998; 46: 299-306.
3. Greenberg S, Frishman WH. Coenzyme Q10 a new drug for cardiovascular disease. J Clin Pharmacol 1990; 30: 596-608.
4. Aberg F, Appelkuist EL, Dallner G, Ernster L. Arch Biochem Biophys 1992; 295: 230-4.
5. Jackson MJ, Edwards RH. Free radicals and trials of antioxidant therapy in muscle disorders. Adv Exp Med Biol 1999; 264: 485-91.
6. Sun IL, Sun EE, Crane FL, Morre VJ, Lindgren A, Low H. Requirement for coenzyme Q10 in plasma membrane electron transport. In: Proc Natl Acad Sci USA 1992; 89: 11126-30.
7. Maxwell SRJ. Prospects for the use of antioxidant therapy. Drugs 1995; 49: 345-61.
8. Singh RB, Wander GS, Rastogi A, Shukla PK, Mittal A, Sharma JP, Mehrotra SK, Kapoor R, Chopra RK. Randomized, double blind, placebo controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther 1998; 12: 347-53.
9. Singh RB, Niaz MA. Serum concentration of lipoprotein(a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role. Int J Cardiol 1999; 68: 23-9.
10. Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens 1999; 13: 203-208.